Advertisement
Screener

LENZ THERAPEUTICS, INC. (LENZ) Other

LENZ THERAPEUTICS, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2024-02-27: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market.
  • 2024-02-27: Form 10-K; Item Shell company; As filed Yes.
  • 2023-11-13: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market.
  • 2023-08-14: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market.
FiledFormItemAs filed
2024-02-2710-KStock registered under Section 12(b)Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market
2024-02-2710-KShell companyYes
2023-11-1310-QStock registered under Section 12(b)Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market
2023-08-1410-QStock registered under Section 12(b)Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market
2023-05-1110-QStock registered under Section 12(b)Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market
2023-04-2710-K/AStock registered under Section 12(b)Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market
2023-03-2010-KStock registered under Section 12(b)Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market
2022-11-0910-QStock registered under Section 12(b)Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market
2022-08-1110-QStock registered under Section 12(b)Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market
2022-05-1210-QStock registered under Section 12(b)Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market
2022-05-1210-QSmaller reporting companyNo
2022-03-2110-KStock registered under Section 12(b)Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market
2021-11-1010-QStock registered under Section 12(b)Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market
2021-08-1210-QStock registered under Section 12(b)Common Stock, par value $0.00001 per share · GRPH · The Nasdaq Global Market
2021-08-1210-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48